Latest News and Events for Neurona Therapeutics

Latest Press Releases

June 29, 2022
Neurona Therapeutics Announces Initial Subject Dosed in First Clinical Trial of Regenerative Human Cell Therapy, NRTX-1001, in Adults with Drug-Resistant Focal Epilepsy

June 17, 2022
Neurona Therapeutics to Present Preclinical Data Supporting Regenerative Cell Therapy, NRTX-1001, in Clinical Development for Chronic Focal Epilepsy, at the ISSCR 2022 Annual Meeting

May 26, 2022
Neurona Therapeutics Awarded $8 Million by California Institute for Regenerative Medicine (CIRM) to Support Phase 1/2 Clinical Trial of NRTX-1001 for Chronic Focal Epilepsy

More Press Releases

photo of neuron

In the news

June 30, 2022
Neurona Therapeutics Dosed Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy

June 29, 2022
Upstate doses first patient in national clinical trial of regenerative human cell therapy for treatment of epilepsy

February 24, 2022
Exploring Cell Therapy for the Treatment of Drug-Resistant Epilepsy

More News Articles

Events

There are currently no upcoming events, please check back.